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Introduction
What is Cardiogenic
Shock?
•
•

•

•

Cardiogenic shock (CS) is a severe
form of acute heart failure (Kataja &
Harjola, 2017).
Severe impairment of myocardial
function leads to end-organ
hypoperfusion (Vahdatpour et al.,
2019).
Characterized by:
•
Hypotension,
•
Low cardiac output
(CO)
•
Systemic
hypoperfusion
The most common cause of
cardiogenic shock is Acute Coronary
Syndrome (ACS) (Kataja & Harjola,
2017).

Why Cardiogenic
Shock?
•

•

•

In my current practice as a
cardiovascular intensive care
(CVICU) nurse, cardiogenic shock is
one of the most frequently seen
diagnoses.
Despite significant research into the
process, it remains a significant
cause of mortality (Vahdatpour et
al., 2019).
Cardiogenic shock is a complex
disease process, which requires
vigilance and timely interventions.

Pathophysiological Processes
Underlying
Pathophysiology

Signs and Symptoms
Cardiogenic shock presents with a variety
of signs and symptoms. Each patient is
unique in their presentation, but
generally all patients with cardiogenic
shock present in a similar manner. As a
result of a poorly functioning ventricle, an
inadequate amount of blood is supplied
to the tissues and patients experience
significant hemodynamic compromise.
Both physical examination, and
hemodynamic monitoring parameters/
monitoring techniques can be used to
evaluate patients (Mebazaa et al., 2018).
The most common symptoms include the
following:
•
Tachycardia
•
Hypotension
•
Low cardiac output/ index
•
Elevated central venous pressure
(CVP)
•
Elevated pulmonary capillary wedge
pressure (PCWP)
•
Cool extremities
•
Weak pulse
•
Tachypnea
•
Shortness of breath
•
Confusion
•
Elevated lactate
•
Low pH
•
Peripheral edema
•
Jugular venous distension
•
Low urine output
(Vahdatpour et al., 2019)

•

•

•

•

•

•

•

Cardiogenic shock is an imbalance
between myocardial oxygen supply
and demand. An insult to the
myocardial tissue leads to a greater
oxygen demand than the heart can
supply.
Acute coronary syndrome accounts
for about 80% of all CS cases (Kataja
& Harjola, 2017, p. 121).
As a result of an acute myocardial
infarction (MI), the myocardium is
deprived of oxygen, and becomes
damaged, leading to left ventricular
systolic dysfunction.
The decreased systolic function leads
to a decrease in cardiac output,
hypotension and hypoperfusion of
vital organs (Kataja & Harjola, 2017).
Cardiogenic shock can also occur as a
result of valvular, electrical or
primary myocardial issues (Brener et
al., 2020).
With a decrease in oxygenation at the
tissue and cellular level, the body
attempts to compensate by increasing
peripheral vasoconstriction, which
further increases the workload of the
damaged myocardium.
Catecholamines are released, which
help to stimulate contractility of the
heart to generate better forward
blood flow, but at the same time
increase the myocardial oxygen
demand (Kataja & Harjola, 2017).

Significance of Pathophysiology
•
•

•

•

Because of the viscous cycle that
occurs with CS, the pathophysiology
is significant.
In normal physiology there is an
equal balance between the right and
left sides of the heart. The amount of
blood ejected over one minute or
cardiac output is the same.
In cardiogenic shock, this balance is
disrupted leading to the backup of
blood into the lungs and periphery.
The poor systolic function of the left
ventricle in patients with
cardiogenic shock leads to a
downward spiral of compensatory
mechanisms within the body.

•
•

References Cited

The poor compensatory mechanisms
are significant and require medical
intervention.
“Compensatory peripheral
vasoconstriction may initially improve
coronary and peripheral perfusion,
however it contributes to increased
cardiac afterload that overburdens
damaged myocardium. This results in
diminished oxygenated blood flow to
peripheral tissue and, ultimately, the
heart” (Vahdatpour et al., 2019, p. 1).

Treatment
•
•

•
•
•
•

The main treatment for CS is identifying the underlying cause and reversing or
treating the underlying cause if possible.
Mechanical support devices which help to maintain adequate cardiac output and
help decrease the workload of the heart. Examples include:
•
Intra-aortic balloon pumps
•
Extracorporeal membrane oxygenation (ECMO)
•
Impella devices
(den Uil et al., 2017)
Intravenous fluids with a goal of maintaining a euvolemic status (Kataja & Harjola,
2017).
Vasoactive medications with the goal of restoring adequate blood pressure and
end-organ perfusion (Vahdatpour et al., 2019).
Hemodynamic monitoring of cardiac output, stroke volume, blood pressure, CVP,
PCWP
Echocardiogram

(Klabunde, n.d.)

Implications for
Nursing Care
•
•

•

•
•

“Physical findings suggestive of the ventricle primarily involved in cardiogenic shock. Often pro-inflammatory states induced
by shock physiology causes a blunted performance of the less affected side. Both sides often contribute to the clinical
presentation and physical exam findings” (Vahdatpour et al., 2019, p. 3).

Most often, patients with cardiogenic shock require
admission to the intensive care unit.
With mechanical support devices such as intra-aortic
balloon pumps or ECMO, these patients require
diligent care and a heightened level of awareness.
Understanding the signs, symptoms and
pathophysiology behind this disease process is
crucial for nurses and other health care professionals
to be able to adequately care for such patients.
The ability to recognize signs of CS can help aid in
prompt diagnosis and treatment.
Advanced knowledge of hemodynamic parameters
and the subtle changes of each parameter is an
important skill to have and crucial while caring for
cardiogenic shock patients.

Conclusion
•

•
•

(Vahdatpour et al., 2019, p. 8)

Despite significant knowledge and understanding of
cardiovascular physiology and the pathophysiology of
cardiogenic shock, mortality rates remain as high as
35-50% (Kataja & Harjola, 2017).
Advanced knowledge of the treatment modalities, and
pathophysiology of cardiogenic shock could help aid in
the reduction of mortality rates.
Vigilant nurses who can identify deteriorating patients
and understand the pathophysiology of CS can notify
necessary healthcare professionals and help improve
patient outcomes.
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